缅北禁地

Skip to main content

Staff Profile

Huw Thomas

Senior Research Associate

  • Telephone: +44 (0) 191 208 4300
  • Address: University of 缅北禁地 Upon Tyne
    Translational and Clinical Research Institute
    Paul O'Gorman Building
    Medical School
    Framlington Place
    缅北禁地 upon Tyne
    NE2 4HH

Background

Qualifications

BSc (hons) Pharmacology 1991
MPhil 1999

Previous Positions

Research Technician 1993-1996
Junior Research associate 1996-2000

Memberships

BACR
PAMM

Research

Research Interests

Pharmacology of novel drugs to treat cancer
Pharmacokinetics

Other Expertise

Analysis of drugs in biological material

Current Work

Evaluation of, novel drugs to inhibit DNA repair-mediated resistance to anticancer therapy, CDK inhibitors and novel nucleoside transport inhibitors to enhance antifolate efficacy.

Postgraduate Supervision

MRes student supervision 2004

Funding

Preclinical and pharmacodynamic studies with Novel DNA-PK inhibitors. N.J. Curtin (PI, 40%) A.H. Calvert (5%), BW Durkacz (10%), BT Golding (5%), RJ Griffin (5%), IR Hardcastle (5%), D.R. Newell (20%), H. Thomas (10%). KuDos Pharmaceuticals 06/02-05/06 £355,171

Preclinical evaluation of DNA-PK and ATM inhibitors. N.J. Curtin (PI, 40%) A.H. Calvert (5%), BW Durkacz (10%), BT Golding (5%), RJ Griffin (5%), IR Hardcastle (5%), D.R. Newell (20%), H. Thomas (10%). KuDos Pharmaceuticals 01/03-12/06 £413,088

Preclinical Evaluation of AT5438 D.R. Newell (PI = 50%) N.J. Curtin (25%), H. Thomas (25%). Astex Technology Ltd 05/03-05/04 £15,253

Publications

  • Articles

    • Scott E, Hodgson K, Calle B, Turner H, Cheung K, Bermudez A, Marques FJG, Pye H, Yo EC, Islam K, Oo HZ, McClurg UL, Wilson L, Thomas H, Frame FM, Orozco-Moreno M, Bastian K, Arredondo HM, Roustan C, Gray MA, Kelly L, Tolson A, Mellor E, Hysenaj G, Goode EA, Garnham R, Duxfield A, Heavey S, Stopka-Farooqui U, Haider A, Freeman A, Singh S, Johnston EW, Punwani S, Knight B, McCullagh P, McGrath J, Crundwell M, Harries L, Bogdan D, Westaby D, Fowler G, Flohr P, Yuan W, Sharp A, de Bono J, Maitland NJ, Wisnovsky S, Bertozzi CR, Heer R, Guerrero RH, Daugaard M, Leivo J, Whitaker H, Pitteri S, Wang N, Elliott DJ, Schumann B, Munkley J. . Oncogene 2023, 42, 926–937.
    • Zaki MYW, Alhasan SF, Shukla R, McCain M, Laszczewska M, Geh D, Patman GL, Televantou D, Whitehead A, Mauricio JP, Barksby B, Gee LM, Paish HL, Leslie J, Younes R, Burt AD, Borthwick LA, Thomas H, Beale GS, Govaere O, Sia D, Anstee QM, Tiniakos D, Oakley F, Reeves HL. . Liver Cancer 2022, 11(6), 540-557.
    • Noble RA, Thomas H, Zhao Y, Herendi L, Howarth R, Dragoni I, Keun HC, Vellano CP, Marszalek JR, Wedge SR. . British Journal of Cancer 2022, 127, 937-947.
    • Miller DC, Reuillon T, Molyneux L, Blackburn T, Cook SJ, Edwards N, Endicott JA, Golding BT, Griffin RJ, Hardcastle I, Harnor SJ, Heptinstall A, Lochhead P, Martin MP, Martin NC, Myers S, Newell DR, Noble RA, Phillips N, Rigoreau L, Thomas H, Tucker JA, Wang L-Z, Waring MJ, Wong A-C, Wedge SR, Noble MEM, Cano C. . Journal of Medicinal Chemistry 2022, 65(9), 6513-6540.
    • Hunter JE, Campbell AE, Butterworth JA, Sellier H, Hannaway NL, Luli S, Floudas A, Kenneth NS, Moore AJ, Brownridge PJ, Thomas HD, Coxhead J, Taylor L, Leary P, Hasoon MSR, Knight AM, Garrett MD, Collins I, Eyers CE, Perkins ND. . Biochemical Journal 2022, 479(19), 2087-2113.
    • Chessari G, Hardcastle IR, Ahn JS, Anil B, Anscome E, Bawn RH, Bevan LD, Blackburn TJ, Buck I, Cano C, Carbain B, Castro J, Cons B, Cully SJ, St Denis J, Endicott JA, Fazal L, Golding BT, Griffin RJ, Haggerty K, Harnor S, Hearn K, Hobson S, Holvey RS, Howard S, Jennings C, Johnson CN, Lunec J, Miller DC, Newell DR, Noble MEM, Reeks J, Revill CH, Riedinger C, Tamanini E, Thomas H, Thompson NT, Vinkovic M, Wedge SR, Williams PA, Wilsher N, Zhang B, Zhao Y. . Journal of Medicinal Chemistry 2021, 64(7), 4071-4088.
    • Bainbridge A, Walker S, Smith J, Patterson K, Dutt D, Ng YM, Thomas HD, Wilson L, McCullough B, Jones D, Maan A, Banks P, McCracken SRC, Gaughan L, Robson CN, Coffey K. . Nucleic Acids Research 2020, 48(10), 5366-5382.
    • Jones D, Wilson L, Thomas H, Gaughan L, Wade MA. . Cancers 2019, 11(8), 1122.
    • Willoughby CE, Jiang Y, Thomas HD, Willmore E, Kyle S, Wittner A, Phillips N, Zhao Y, Tudhope SJ, Prendergast L, Junge G, Lourenco LM, Finlay MRV, Turner P, Munck JM, Griffin RJ, Rennison T, Pickles J, Cano C, Newell DR, Reeves HL, Ryan AJ, Wedge SR. . Journal of Clinical Investigation 2019, 130, 1-14.
    • Chen L, Pastorino F, Berry P, Bonner J, Kirk C, Wood KM, Thomas HD, Zhao Y, Daga A, Veal GJ, Lunec J, Newell DR, Ponzoni M, Tweddle DA. . International Journal of Cancer 2019, 144(12), 3146-3159.
    • Myers SM, Miller DC, Molyneux L, Arasta M, Bawn RH, Blackburn TJ, Cook SJ, Edwards N, Endicott JA, Golding BT, Griffin RJ, Hammonds T, Hardcastle IR, Harnor SJ, Heptinstall AB, Lochhead PA, Martin MP, Martin NC, Newell DR, Owen PJ, Pang LC, Reuillon T, Rigoreau LJM, Thomas HD, Tucker JA, Wang L-Z, Wong A-C, Noble MEM, Wedge SR, Cano C. . European Journal of Medicinal Chemistry 2019, 178, 530-543.
    • Matheson EC, Thomas H, Case M, Blair H, Jackson RK, Masic D, Veal G, Halsey C, Newell DR, Vormoor J, Irving JAE. . Haematologica 2019, 104(9), 1804-1811.
    • Coxon RC, Wong C, Bayliss R, Boxall K, Carr KH, Fry AM, Hardcastle IR, Matheson CJ, Newell DR, Sivaprakasam M, Thomas H, Turner D, Yeoh S, Wang LZ, Griffin RJ, Golding BT, Cano C. . Oncotarget 2017, 8, 19089-19124.
    • Almeida GS, Bawn CM, Galler M, Wilson I, Thomas HD, Kyle S, Curtin NJ, Newell DR, Maxwell RJ. . NMR in Biomedicine 2017, 30(9), e3736.
    • Noble RA, Bell N, Blair H, Sikka A, Thomas H, Phillips N, Nakjang S, Miwa S, Crossland R, Rand V, Televantou D, Long A, Keun HC, Bacon CM, Bomken S, Critchlow SE, Wedge SR. . Haematologica 2017, 102(7), 1247-1257.
    • McCormick A, Earp E, Elliot K, Cuthbert G, O'Donnell R, Wilson BT, Sutton R, Leeson C, Thomas HD, Blair H, Fordham S, Lunec J, Allan J, Edmondson RJ. . Oncotarget 2017, 8(16), 26832-26844.
    • Hunter JE, Butterworth JA, Zhao B, Sellier H, Campbell KJ, Thomas HD, Bacon CM, Cockell SJ, Gewurz BE, Perkins ND. . Oncogene 2016, 35(26), 3476-3484.
    • Haagensen EJ, Thomas HD, Mudd C, Tsonou E, Wiggins CM, Maxwell RJ, Moore JD, Newell DR. . European Journal of Cancer 2016, 56, 69-76.
    • Haagensen EJ, Thomas HD, Schmalix WA, Payne AC, Kevorkian L, Allen RA, Bevan P, Maxwell RJ, Newell DR. . Cancer Chemotherapy and Pharmacology 2016, 78(6), 1269-1281.
    • Beale G, Haagensen E, Thomas H, Wang LZ, Revill C, Payne S, Golding BT, Hardcastle IR, Newell DR, Griffin RJ, Cano C. . British Journal of Cancer 2016, 115, 682-690.
    • McCrudden CM, O'Rourke MG, Cherry KE, Yuen HF, O'Rourke D, Babur M, Telfer BA, Thomas HD, Keane P, Nambirajan T, Hagan C, O'Sullivan JM, Shaw C, Williams KJ, Curtin NJ, Hirst DG, Robson T. . PLoS One 2015, 10(2).
    • Cornell L, Munck JM, Alsinet C, Villanueva A, Ogle L, Willoughby CE, Televantou D, Thomas HD, Jackson J, Burt AD, Newell D, Rose J, Manas DM, Shapiro GI, Curtin NJ, Reeves HL. . Clinical Cancer Research 2015, 21(4), 925-933.
    • Murray J, Thomas H, Berry P, Kyle S, Patterson M, Jones C, Los G, Hostomsky Z, Plummer ER, Boddy AV, Curtin NJ. . British Journal of Cancer 2014, 110, 1977-1984.
    • Roughan JV, Coulter CA, Flecknell PA, Thomas HD, Sufka KJ. . PLoS One 2014, 9(8), e103362.
    • Haagensen EJ, Thomas HD, Wilson I, Harnor SJ, Payne SL, Rennison T, Smith KM, Maxwell RJ, Newell DR. . PLoS ONE 2013, 8(12), e81763.
    • Hill CR, Jamieson D, Thomas HD, Brown CDA, Boddy AV, Veal GJ. . Biochemical Pharmacology 2013, 85(1), 29-37.
    • Bell E, Ponthan F, Whitworth C, Thomas H, Redfern CPF. . PLoS One 2013, 8(7), e68859.
    • Jarvis IWH, Meczes EL, Thomas HD, Edmondson RJ, Veal GJ, Boddy AV, Ottley CJ, Pearson DG, Tilby MJ. . Biochemical Pharmacology 2012, 83(1), 69-77.
    • Hepburn AC, Veeratterapillay R, Williamson SC, El-Sherif A, Sahay N, Thomas HD, Mantilla A, Pickard RS, Robson CN, Heer R. . PLoS One 2012, 7(11), e50690.
    • Drew Y, Mulligan EA, Vong W, Thomas HD, Kahn S, Kyle S, Mukhopadhyay A, Los G, Hostomsky Z, Plummer ER, Edmondson RJ, Curtin NJ. . Journal of the National Cancer Institute 2011, 103(4), 334-346.
    • Ali M, Kamjoo M, Thomas HD, Kyle S, Pavlovska I, Babur M, Telfer BA, Curtin NJ, Williams KJ. . Molecular Cancer Therapeutics 2011, 10(12), 2320-2329.
    • Thomas HD, Wang LZ, Roche C, Bentley J, Cheng YZ, Hardcastle IR, Golding BT, Griffin RJ, Curtin NJ, Newell DR. . European Journal of Cancer 2011, 47(13), 2052-2059.
    • Zaremba T, Thomas HD, Cole M, Coulthard SA, Plummer ER, Curtin NJ. . Biochemical Journal 2011, 436(3), 671–679.
    • Saravanan K, Barlow HC, Barton M, Calvert AH, Golding BT, Newell DR, Northen JS, Curtin NJ, Thomas HD, Griffin RJ. . Journal of Medicinal Chemistry 2011, 54(6), 1847-1859.
    • Johnson N, Li YC, Walton ZE, Cheng KA, Li DA, Rodig SJ, Moreau LA, Unitt C, Bronson RT, Thomas HD, Newell DR, D'Andrea AD, Curtin NJ, Wong KK, Shapiro GI. . Nature Medicine 2011, 17(7), 875-882.
    • Zaremba T, Thomas H, Cole M, Plummer ER, Curtin NJ. . Cancer Chemotherapy and Pharmacology 2010, 66(4), 807-812.
    • Daniel RA, Rozanska AL, Mulligan EA, Drew Y, Thomas HD, Castelbuono DJ, Hostomsky Z, Plummer ER, Tweddle DA, Boddy AV, Clifford SC, Curtin NJ. . British Journal of Cancer 2010, 103(10), 1588-1596.
    • Issaeva N, Thomas HD, Djurenovic T, Jaspers JE, Stoimenov I, Kyle S, Pedley N, Gottipati P, Zur R, Sleeth K, Chatzakos V, Mulligan EA, Lundin C, Gubanova E, Kersbergen A, Harris AL, Sharma RA, Rottenberg S, Curtin NJ, Helleday T. . Cancer Research 2010, 70(15), 6268-6276.
    • Ali M, Telfer BA, McCrudden C, O'Rourke M, Thomas HD, Kamjoo M, Kyle S, Robson T, Shaw C, Hirst DG, Curtin NJ, Williams KJ. . Clinical Cancer Research 2009, 15(19), 6106-6112.
    • Darby S, Murphy T, Thomas H, Robson CN, Leung HY, Mathers ME, Gnanapragasam VJ. . British Journal of Cancer 2009, 101(11), 1891-1899.
    • Thomas HD, Saravanan K, Wang LZ, Lin MJ, Northen JS, Barlow H, Barton M, Newell DR, Griffin RJ, Golding BT, Curtin NJ. . Molecular Cancer Therapeutics 2009, 8(7), 1828-1837.
    • Daniel RA, Rozanska AL, Thomas HD, Mulligan EA, Drew Y, Castelbuono DJ, Hostomsky Z, Plummer ER, Boddy AV, Tweddle DA, Curtin NJ, Clifford SC. . Clinical Cancer Research 2009, 15(4), 1241-1249.
    • Kyle S, Thomas HD, Mitchell J, Curtin NJ. . British Journal of Radiology 2008, 81(Special Issue 1), S6-S11.
    • Thomas HD, Calabrese CR, Batey M, Canan S, Hostomsky Z, Kyle S, Maegley K, Newell DR, Skalitzky D, Wang L, Webber SE, Curtin NJ. . Molecular Cancer Therapeutics 2007, 6(3), 945-956.
    • Armstrong J, Taylor GA, Thomas HD, Boddy AV, Redfern C, Veal GJ. . British Journal of Cancer 2007, 96(11), 1675-1683.
    • Graham-Cole C, Thomas HD, Taylor GA, Newell DR, Melton R, Hesp R, Boddy AV. . Cancer Chemotherapy and Pharmacology 2007, 59(2), 197-206.
    • Zhao Y, Thomas HD, Batey M, Cowell I, Richardson C, Griffin RJ, Calvert AH, Newell DR, Smith G, Curtin NJ. . Cancer Research 2006, 66(10), 5354-5362.
    • Veal GJ, Errington J, Thomas HD, Boddy AV, Lowis S. . Cancer Chemotherapy and Pharmacology 2006, 58(3), 415-417.
    • Bryant H, Schultz N, Thomas HD, Parker K, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T. . Nature 2005, 434(7035), 913-917.
    • Tikhe J, Webber S, Hostomsky Z, Maegley K, Ekkers A, Li J, Yu X, Almassy R, Kumpf R, Boritzki T, Zhang C, Calabrese C, Curtin NJ, Kyle S, Thomas HD, Wang L, Calvert AH, Golding B, Griffin RJ, Newell DR. . Journal of Medicinal Chemistry 2004, 47(22), 5467-5481.
    • Calabrese C, Almassy R, Barton S, Batey M, Calvert AH, Canan-Koch S, Durkacz B, Hostomsky Z, Kumpf R, Kyle S, Li J, Maegley K, Newell DR, Notarianni E, Stratford I, Skalitzky D, Thomas HD, Wang L, Webber S, William K, Curtin NJ. . Journal of the National Cancer Institute 2004, 96(1), 56-67.
    • Calabrese C, Batey M, Thomas HD, Durkacz B, Wang L, Kyle S, Skalitzky D, Li J, Zhang C, Boritzki T, Maegley K, Calvert AH, Hostomsky Z, Newell DR, Curtin NJ. . Clinical Cancer Research 2003, 9(7), 2711-2718.
    • Thomas HD, Porter D, Bartelink I, Nobbs J, Cole M, Elliott S, Newell DR, Calvert AH, Highley M, Boddy AV. . British Journal of Clinical Pharmacology 2002, 53(1), 83-91.
    • Koch SSC, Thoresen LH, Tikhe JG, Maegley KA, Almassy RJ, Li JK, Yu XH, Zook SE, Kumpf RA, Zhang C, Boritzki TJ, Mansour RN, Zhang KE, Ekker A, Calabrese CR, Curtin NJ, Kyle S, Thomas HD, Wang LZ, Calvert AH, Golding BT, Griffin RJ, Newell DR, Webber SE, Hostomsky Z. . Journal of Medicinal Chemistry 2002, 45(23), 4961-4974.
    • Boddy AV, Griffin MJ, Sludden J, Thomas HD, Fishwick KA, Wright J, Plummer ER, Highley MS, Calvert AH. . Cancer Chemotherapy and Pharmacology 2001, 48(1), 15-21.
    • Smith PG, Thomas HD, Barlow HC, Griffin RJ, Golding BT, Calvert AH, Newell DR, Curtin NJ. . Clinical Cancer Research 2001, 7(7), 2105-2113.
    • Marshman, E., Taylor, G., Thomas, H., Newell, D.R., Curtin, N.J. . Biochemical Pharmacology 2001, 61(4), 477-484.
    • Thomas HD, Boddy AV, English M, Hobson R, Imeson J, Lewis I, Morland B, Pearson ADJ, Pinkerton R, Price L, Stevens M, Newell DR. . Journal of Clinical Oncology 2000, 18(21), 3614-3621.
    • Thomas HD, Lind M, Ford J, Bleehen N, Calvert AH, Boddy AV. . Cancer Chemotherapy and Pharmacology 2000, 45(4), 284-290.
    • Boddy AV, Griffin MJ, Wright JG, Sludden JA, Thomas HD, Fishwick K, Plummer R, Highley M, Calvert AH. . British Journal of Cancer 2000, 83(Suppl. 1), 79-79.
    • Calabrese CR, Curtin NJ, Canan-Koch SS, Batey MA, Thomas HD, Kyle S, Wang LZ, Boritzki TJ, Webber SE, Griffin RJ, Golding BT, Hostomsky Z, Calvert AH, Newell DR. . Clinical Cancer Research 2000, 6(Suppl. 1), 4496 No. 150.
    • Smith PG, Thomas HD, Barlow HC, Griffin RJ, Golding BT, Calvert AH, Newell DR, Curtin NJ. . Clinical Cancer Research 2000, 6(Suppl. 1), 4555S-4555S.
    • Veal GJ, Boddy AV, Thomas HD, Price E, Parry A, Hale J, Pearson ADJ, Dick G, Atra A, Newell DR. . British Journal of Cancer 1999, 80(Suppl. 2), 93-93.
    • Calabrese CR, Thomas HD, Batey MA, Boritzki T, Zhang K, White AW, Curtin NJ, Griffin RJ, Golding BT, Hostomsky Z, Calvert AH, Newell DR. . Clinical Cancer Research 1999, 5(Suppl. 1), S3839-S3839.
    • Calabrese CR, Thomas HD, Srinivasan S, White AW, Boritzki T, Canon-Koch S, Zhang K. . British Journal of Cancer 1999, 80(supplement 2), 93 P260.
    • Thomas HD, Boddy AV, Pearson ADJ, Pinkerton CR, Lewis I, Stevens M, Imeson J, Hobson R, Newell DR. . British Journal of Cancer 1998, 78(Suppl.1), 9-9.
    • Bisogno G, Cowie F, Boddy AV, Thomas HD, Dick G, Pinkerton C. . British Journal of Cancer 1998, 77(12), 2304-2309.
    • Siddiqui N, Boddy AV, Thomas HD, Bailey N, Robson L, Lind M, Calvert AH. . British Journal of Cancer 1997, 75(2), 287-294.
    • Porter D, Boddy AV, Thomas HD, Lind M, Newell DR, Calvert AH, Robson L, Brampton M, Abrahamsen D, Winograd B. . Seminars in Oncology 1996, 23(6 supplement 13), 34-44.
    • Mummaneni V, Kaul S, Igwemezie L, Newell DR, Porter D, Thomas HD, Calvert AH, Winograd B, Barbhaiya R. . Journal of Pharmacokinetics and Biopharmaceutics 1996, 24(4), 313-325.
    • Laohavinij S, Wedge S, Lind M, Bailey N, Humphreys A, Proctor M, Chapman F, Simmons D, Oakley A, Robson L, Gumbrell L, Taylor G, Thomas HD, Boddy AV, Newell DR, Calvert AH. . Investigational New Drugs 1996, 14(3), 325-335.
    • Calvert AH, Boddy AV, Bailey NP, Siddiqui N, Humphreys A, Hughs A, Robson L, Gumbrell L, Thomas H, Chapman F, Proctor M, Simmons D, Oakey A, Lind MJ, Sinha DV, Newell DR. . Seminars in Oncology 1995, 22(5 Suppl. 12), 91-98.

  • Conference Proceedings (inc. Abstracts)

    • Tomassini S, Gentles L, Kirk C, Cross P, Thomas H, Wedge S, Curtin NJ, O'Donnell RL. . In: BASO - The Association for Cancer Surgery Annual Scientific Conference and the NCRI Cancer Conference. 2017, Liverpool: Elsevier.
    • Maegley KA, Bingham P, Tatlock JH, Thomas HD. All PARP inhibitors are not equal: An in vitro mechanistic comparison of PF-01367338 to iniparib. In: JOURNAL OF CLINICAL ONCOLOGY. 2011, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA: AMER SOC CLINICAL ONCOLOGY.
    • Issaeva N, Thomas HD, Pedley N, Djurenovic T, Lundin C, Gubanova E, Sleeth K, Stoimenov I, Chatzakos V, Zdzienicka MZ, Curtin NJ, Helleday T. Exploiting Homologous Recombination Repair Defects in Cancer Cells. In: ENVIRONMENTAL AND MOLECULAR MUTAGENESIS. 2009, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA: WILEY-LISS.
    • Issaeva N, Thomas HD, Pedley N, Djurenovic T, Lundin C, Gubanova E, Sleeth K, Stoimenov I, Chatzakos V, Zdzienicka MZ, Curtin NJ, Helleday T. . In: Environmental and Molecular Mutagenesis: Environmental Mutagen Society 40th Annual Meeting, Genomics in the Environmental Society. 2009, St. Louis, Missouri: John Wiley & Sons, Inc.
    • Daniel RA, Rozanska A, Mulligan EA, Drew E, Thomas HD, Castelbuono D, Tweddle DA, Boddy AV, Plummer ER, Hostomsky Z, Curtin NJ, Clifford SC. . In: Proceedings of the 100th Annual Meeting of the American Association for Cancer Research. 2009, Denver, CO: American Association for Cancer Research.
    • Williams K, Telfer B, Ali M, Kamjoo M, Thomas H, O'Rourke M, McCrudden C, Hirst D, Curtin NJ. . In: Proceedings of the 99th Annual Meeting of the American Association for Cancer Research. 2008, San Diego, California, USA: American Association for Cancer Research.
    • Newell D, Thomas HD, Wang L, Roche C, Bentley J, Cheng Y, Hardcastle I, Golding B, Griffin R, Curtin NJ. . In: Proceedings of the 99th Annual Meeting of the American Association for Cancer Research. 2008, San Diego, California, USA: American Association for Cancer Research.
    • Clifford S, Daniel R, Rozanska A, Thomas HD, Boddy AV, Tweddle DA, Curtin NJ. . In: 39th International Conference of the International Society for Pediatric Oncology. 2007, National Centre for Performing Arts, Mumbai, India: Pediatric Blood and Cancer.
    • Thomas HD, Calabrese CR, Canan S, Hostomsky ZKS, Maegley K, Newell DR, Skalitzki D, Wang L, Curtin NJ. . In: 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. 2006, Prague, Czech Republic: European Journal of Cancer Supplements: Pergamon.

  • Review

    • Boddy AV, Thomas HD. . CNS Drugs 1997, 7(4), 257-263.